700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|National Institutes of Health, USA|
|ScientificTracks Abstracts: J Genet Syndr Gene Ther|
|Zika virus infection with complications of microcephaly and other complications has emerged as a health threat in many countries where the infection has been reported in over 60 countries. Vaccines and therapeutics are currently unavailable for the Zika virus infection. We have developed several compound screening assays and carried out the drug repurposing screens to identify potential therapeutics for the Zika virus infection. The newest results on drug repurposing screens and Zika virus drug development will be presented in this talk.|
Wei Zheng received his PhD in Pharmacology from the State University of New York at Buffalo. He had worked for 12 years in pharmaceutical companies (Berlex, Amgen, and Merck) for drug discovery and development. Since 2005, he has worked at National Institutes of Health for development of therapeutics for rare and neglected diseases. He has identified several drugs from drug repurposing screens and advanced two of them to clinical trials. Currently, he is working on the therapeutics development for lysosomal storage diseases, drug resistant cancer and infectious diseases.
Email: [email protected]
|PDF | HTML|